A Novel β-lactam/β-lactamase Inhibitor: Ceftolozane/tazobactam [Yeni Bir β-laktam/β-laktamaz İnhibitörü: Seftolozan/tazobaktam]

dc.contributor.author	Şerefhanoğlu, K.
dc.date.accessioned	2021-12-21T08:40:54Z
dc.date.available	2021-12-21T08:40:54Z
dc.date.issued	2019
dc.identifier.issn	2147673X
dc.identifier.uri	https://doi.org/10.4274/mjima.galenos.2019.2019.10
dc.identifier.uri	http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/1248
dc.description.abstract	Ceftolozane/tazobactam is a novel generation cephalosporin and β-lactamase inhibitor combination antibiotic. It was approved for the treatment of adults (18 years and older) with complicated intraabdominal infections used in combination with metronidazole
dc.language.iso	English
dc.publisher	Galenos
dc.rights	All Open Access, Gold
dc.title	A Novel β-lactam/β-lactamase Inhibitor: Ceftolozane/tazobactam [Yeni Bir β-laktam/β-laktamaz İnhibitörü: Seftolozan/tazobaktam]
dc.type	Review
dc.relation.journal	Mediterranean Journal of Infection, Microbes and Antimicrobials
dc.identifier.volume	8
dc.identifier.doi	10.4274/mjima.galenos.2019.2019.10
dc.relation.volume	8

Bu öğenin dosyaları:

Dosyalar	Boyut	Biçim	Göster
Bu öğe ile ilişkili dosya yok.